Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Acamprosate

Drug Profile

Acamprosate

Alternative Names: Acamprosate calcium; Alcomed; Aotal; Calcium acetylhomotaurinate; Campral; Campral EC; NS-11; Regtect; Sobriol; Zulex

Latest Information Update: 04 Nov 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Laboratoires Meram
  • Developer Merck Lipha Sante; Nippon Shinyaku
  • Class Alkanesulfonic acids; Behavioural disorder therapies; Drug withdrawal therapies; Small molecules
  • Mechanism of Action GABA receptor agonists; Glutamate receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Alcoholism

Most Recent Events

  • 01 Jul 2014 Forest Laboratories has been acquired by Actavis Inc
  • 27 May 2013 Launched for Alcoholism in Japan (PO)
  • 25 Mar 2013 Registered for Alcoholism in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top